Fusen Pharma Unit to Raise 300 Million Yuan From State-Owned Investors
Fusen Pharmaceutical (HKG:1652) said its unit, Henan Fusen Pharmaceutical, agreed to raise 300 million yuan through a capital increase from two state-owned investors, according to a Thursday Hong Kong bourse filing.Nanyang Industrial Investment and Henan Xisheng will subscribe for newly issued equity representing about 34% of Henan Fusen's enlarged registered capital.Following the transaction, Fusen Pharmaceutical's indirect stake in the unit will decrease to about 66%, while the unit will remain a subsidiary.The proceeds will be used mainly to repay debt and replenish working capital.